Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
May 2008
Features
Letters to the Editor
Drug Utilization Evaluation
Prescribing Trends with Daptomycin (Cubicin) for the Treatment of Gram-Positive Infections
The injectable agent daptomycin, when prescribed according to approved guidelines, can be a welcome option for treating some multiresistant, gram-positive infections that have become increasingly prevalent.
Noreen H. Chan Tompkins, PharmD, and Stephen J. Harnicar, PharmD
Effect of Persistence with Drug Therapy on the Risk of Myocardial Re-infarction
Medicaid patients who continued with their initial MI-preventive therapy (beta blockers, calcium-channel blockers, or statins) after a heart attack were more likely to avoid re-infarction and death.
Fadia T. Shaya, PhD, MPH; Anna Gu, PhD, MS; and Xia Yan, MS
Meeting Highlights
American College of Cardiology 57th Scientific Sessions, 2008
Presentations cover comparisons of ezetimibe/simvastatin (Vytorin) versus Zocor alone for reducing cholesterol; amlodipine/atorvastatin (Caduet) for preventing myocardial ischemia; extended-release niacin/laropiprant (Cordaptive) for lowering lipid levels; and bivalirudin (Angiomax) versus unfractionated heparin for reducing bleeding after coronary procedures.
Reuben B. David
Pharmaceutical Approval Update
Topics include bendamustine (Treanda) for chronic lymphocytic leukemia, hepatitis B immune globulin (HepaGam B) to prevent hepatitis B infection following liver transplantation, and a fibrin sealant (Artiss) used in skin graft surgery for burn patients.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Open Public Hearing No. 4: My Fight for Nonprescription Mevacor
David Nash, MD, MBA, recounts his testimony before the FDA in which he supported bringing lovastatin (Mevacor) over the counter.
David Nash, MD, MBA
Medication Errors
Template for Disaster? Fatal Injection into Wrong Port of Implanted Infusion Pump
Matthew Grissinger, RPh, FASCP, describes the potential for fatal mishaps when the wrong port is selected during the refilling of implantable infusion pumps used for delivering opiates.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Medicare Adopts e-Prescribing Standards for Formularies – But More Tweaking Needed
Stephen Barlas delves into some of the shortcomings of Medicare’s adoption of new electronic prescribing standards for formularies.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From Aplenzin to Treximet, P&T presents the latest studies and information about FDA approvals, new indications, recalls, and industry updates.
Drug Forecast
Omega-3-acid Ethyl Esters (Lovaza) for Severe Hypertriglyceridemia
Omega-3-acid ethyl esters (Lovaza) are now available for treating patients with severe hypertriglyceridemia.
Renee R. Koski, PharmD, CACP
